Epcoritamab (Anti-CD20 & CD3)
Product Specifications
CAS Number
2134641-34-0
Synonyms
GEN3013, DuoBody-CD3xCD20
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Epcoritamab is a bispecific IgG1 antibody that targets CD3 and CD20, exhibiting strong T-cell-mediated cytotoxic activity against CD20+ malignant B cells. It is used in the treatment of adults in relapsed or refractory (R/R) large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma after ≥2 lines of systemic treatment. MW: 145.26 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
APG02858G 0.1mg
Monoclonal CYP1B1 Antibody (monoclonal) (M03), Clone: 2F8
Sign In for Pricing
View Details 